Products

Huxley SANSA Home Sleep Apnea Test (1000-00)
Huxley Medical
Cardiology AI
Huxley SANSA is an FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis, offering an app-free, cellular-enabled solution for streamlined patient care.
SANSA HSAT
Huxley Medical
Neurology AI
Huxley Medical's SANSA HSAT is an FDA-cleared, AI-powered, app-free chest-worn diagnostic patch for home sleep apnea testing, providing streamlined diagnosis of Obstructive and Central Sleep Apnea by analyzing 9 physiological data channels.

See all 2 products →

About Huxley Medical

Huxley Medical is a privately held medical technology company dedicated to developing advanced diagnostic solutions that enhance patient care, particularly within the realm of cardiopulmonary health. The company leverages proprietary expertise in biosensor development, physiological signal analysis, and artificial intelligence to create innovative medical devices.

Their flagship product, SANSA, is an FDA-cleared, chest-worn, multi-sensor patch designed to streamline the diagnosis of sleep apnea, including both obstructive and central sleep apnea, while simultaneously providing diagnostic ECG monitoring for cardiac arrhythmias such as atrial fibrillation. SANSA aims to simplify clinical workflows for physicians by offering a single-point-of-contact, app-free, and cellular-enabled home testing solution, thereby eliminating the need for multiple devices, wires, or smartphone applications. This integrated approach is intended to bridge the diagnostic and management gap between cardiology and sleep medicine, facilitating earlier detection and more efficient treatment of co-existing conditions.

Focus Areas

Sleep apnea diagnosis cardiopulmonary care cardiac arrhythmias home sleep testing biosensor development physiological signal analysis artificial intelligence

Business Intelligence

Key InvestorsGRA Venture Fund, National Science Foundation, National Institutes of Health, Invest Georgia, Georgia Tech Foundation Research Impact Fund, Duke Capital Partners
PartnershipsUniversity of Pennsylvania, University of Michigan, Emory University, Atrium Health Wake Forest Baptist, Penn State University, Mayo Clinic, Duke University
TechnologyCloud-connected, multi-diagnostic patch, advanced signal processing, artificial intelligence, biosensor development
FDA Clearances4 cleared products (estimated)

What Physicians Need to Know

Sleep Apnea & Home Testing
Huxley Medical specializes in advanced sleep apnea diagnosis, with a strong emphasis on convenient and accurate home sleep testing solutions, enhancing patient accessibility and comfort.
Cardiopulmonary & Arrhythmia Care
They provide expertise in comprehensive cardiopulmonary care, including the precise diagnosis and management of cardiac arrhythmias, leveraging advanced monitoring techniques.
Advanced Diagnostics & AI
Huxley Medical drives innovation through proprietary biosensor development, sophisticated physiological signal analysis, and the application of artificial intelligence for enhanced diagnostic accuracy and predictive insights.
Physician Tip

Huxley Medical offers physicians a unique blend of cutting-edge biosensor technology and AI-driven analytics for more precise and efficient diagnosis of sleep apnea and cardiac arrhythmias. Their focus on home sleep testing streamlines patient pathways, reduces clinic burden, and improves patient compliance. The integration of physiological signal analysis and AI promises deeper, actionable insights for personalized patient management and potentially earlier intervention.

Given their specialization in home testing and AI-driven analysis, seamless integration with existing Electronic Medical Record (EMR) systems and health data platforms would be crucial for optimizing workflow, data accessibility, and comprehensive patient management for physicians.

Products by Huxley Medical

2 products in the directory

Huxley SANSA Home Sleep Apnea Test (1000-00)
Huxley Medical
Cardiology AI
Huxley SANSA is an FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis, offering an app-free, cellular-enabled solution for streamlined patient care.
SANSA HSAT
Huxley Medical
Neurology AI
Huxley Medical's SANSA HSAT is an FDA-cleared, AI-powered, app-free chest-worn diagnostic patch for home sleep apnea testing, providing streamlined diagnosis of Obstructive and Central Sleep Apnea by analyzing 9 physiological data channels.

What the Web Says

Huxley Medical is a medical technology company focused on cardiopulmonary care, particularly known for its FDA-cleared SANSA home sleep apnea diagnostic patch. The company has received significant funding and is expanding its technology portfolio. Employer reviews are scarce and mixed, with some indicating a positive work environment with learning opportunities and employee recognition, while others, particularly concerning a recruitment agency also named Huxley, point to issues with communication and irrelevant job offerings.

Overall: Mixed

Strengths

  • SANSA patch is FDA-cleared for diagnosing sleep apnea and cardiac arrhythmias.
  • The SANSA device offers high accuracy, sensitivity, and patient comfort.
  • Single-point-of-contact design for SANSA simplifies home sleep testing.
  • Cellular data upload for SANSA eliminates connectivity issues and streamlines data transmission.
  • Huxley Medical encourages career growth and provides learning opportunities.
  • Employee recognition is a regular practice at Huxley Medical.

Limitations

  • Limited employer reviews specifically for Huxley Medical, making a comprehensive assessment difficult.
  • Some Reddit discussions about a recruitment agency named Huxley indicate poor communication and irrelevant job postings.
  • The SANSA device is prescription-use only, limiting direct consumer access.
  • Some users on Reddit found the home sleep apnea tests (general, not specifically SANSA) to be impersonal.
  • The cost of Health Cloud software, which may be related to Huxley Medical's offerings, can be high for smaller teams.
  • Occasional glitches noted in some medical software platforms (general, not specifically Huxley Medical products) on G2 and Capterra.

Based on reviews from: SimplyHired, Reddit, SimplyHired, Sleep Review, Indeed.com, PR Newswire, Xtalks, accessdata.fda.gov, YouTube, Frontiers in Neurology, Trustpilot, Capterra, G2

Last updated: 2026-07-18

Videos

News, demos, and interviews about Huxley Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Huxley Medical →

View all on YouTube

Press & Coverage

PR Newswire
Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker
Huxley Medical introduced SANSA GOu2122, a point-of-care enrollment model, and hypoxic burden, an additional cardiovascular risk marker, to its SANSA platform, expanding access to sleep apnea testing.
2026-06
PR Newswire
Huxley Medical Announces Commercial Launch of FDA-Cleared Central Sleep Apnea Detection and Appointment of Medical Director of Sleep Medicine
Huxley Medical announced FDA 510(k) clearance and commercial launch of central sleep apnea detection for its SANSAu00ae home sleep apnea test and the appointment of Nancy A. Collop, MD, as Medical Director of Sleep Medicine.
2025-12
PR Newswire
Huxley Medical's SANSA Receives Diagnostic ECG Clearance from FDA, Paving Way for First Solution to Systematically Detect Arrhythmias During Home Sleep Testing
Huxley Medical's SANSA home sleep apnea test received FDA clearance to be used as a diagnostic ECG monitor, making it the first home sleep apnea test capable of offering diagnostic insight into cardiac arrhythmias.
2025-12
BioSpace
Huxley Medical Announces FDA Clearance for Cellular-Enabled SANSA Home Sleep Apnea Test
Huxley Medical received FDA clearance for its SANSA home sleep apnea test to use cellular data upload capabilities, eliminating the need for Bluetooth pairing or smartphone apps.
2025-02
Frontiers in Neurology (via NIH)
Polysomnography validation of SANSA to detect obstructive sleep apnea
A multicenter study of 340 participants demonstrated that Huxley Medical's SANSA home sleep apnea test performed comparably to in-laboratory polysomnography for diagnosing obstructive sleep apnea.
2025-06
Medical Device Network
Huxley Medical's sleep apnoea diagnostic patch receives FDA clearance
Huxley Medical received FDA 510(k) clearance for its SANSA sleep apnea diagnostic patch, a chest-worn device designed to simplify sleep apnea diagnosis using AI and advanced signal processing.
2024-08
Tracxn
Huxley Medical - 2026 Funding Rounds & List of Investors
Huxley Medical has raised a total of $28.9 million over 8 funding rounds, including 5 early-stage, 1 debt, and 2 grant rounds, with its largest being a Series A in November 2025.
2026-04
TMX Newsfile
Huxley Health Inc. Introduces Aerasyn Biotech Division, Expands Leadership and Scalable IP Platform, Engages Capital Partner for Up to $15M Financing and Prepares to Go Public Amid Growing U.S. Policy and Public Discourse on Psychedelics
Huxley Health Inc. introduced its Aerasyn Biotech Division, engaged a capital markets partner for up to $15 million in financing, and is preparing for a potential public listing, focusing on non-hallucinogenic technologies and scalable manufacturing solutions.
2026-04

Frequently Asked Questions

Huxley Medical's primary product is the SANSA home sleep apnea test, an FDA-cleared, chest-worn patch designed for the diagnosis of sleep-related breathing disorders. This innovative biosensor device measures 8-9 physiological channels, including blood oxygen saturation, respiratory effort, and sleep staging, without the need for wires or additional attachments, simplifying the diagnostic process.
The SANSA device uniquely integrates a diagnostic ECG monitor, allowing for the systematic detection of cardiac arrhythmias like atrial fibrillation simultaneously with sleep apnea testing. This capability positions the SANSA platform at the intersection of cardiology and sleep medicine, streamlining care for patients with comorbid conditions.
Huxley Medical's SANSA device utilizes advanced signal processing and artificial intelligence (AI) to detect sleep-disordered breathing and generate automated reports from the collected physiological data. The company addresses AI concerns through rigorous clinical validation and FDA clearances, demonstrating the accuracy and reliability of its AI-powered algorithms in diagnosing both obstructive and central sleep apnea.
For patients, SANSA offers improved comfort and compliance due to its non-invasive, single-point-of-contact, wire-free, and app-free design, with data uploaded via built-in cellular technology. For physicians, it streamlines workflows by eliminating lengthy referral processes and multiple clinic visits, providing near real-time data and AI-powered auto-scoring for efficient diagnosis and management.
Huxley Medical's SANSA device has received multiple 510(k) clearances from the U.S. Food and Drug Administration (FDA) for obstructive sleep apnea diagnosis, diagnostic ECG monitoring for cardiac arrhythmias, and central sleep apnea detection. These clearances, along with extensive clinical trials, demonstrate the company's commitment to regulatory compliance and product efficacy.
While specific pricing structures are not publicly detailed, Huxley Medical aims to offer a significantly less expensive solution compared to traditional home sleep tests, as noted in earlier reports. They provide comprehensive support for healthcare providers, including direct-to-patient test delivery and 24/7 live support to ensure seamless integration and operation.
Huxley Medical, founded in 2019, is a privately held, commercial-stage medical technology firm that has raised over $20 million in investment capital and grant funding, indicating solid financial stability. The company actively collaborates with clinician customers and physician investigators to develop and validate its diagnostic solutions.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.